Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Boer

Showing results (71-80 of 217) with videos related to

Pageof 22
Sort By:
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Change in the renin dependency of blood pressure induced by volume depletion and/or propranolol therapy in hypertensive patientsG G Geyskes, P Boer, J Vos, et al.
Lancet (London, England)|May 15, 1976
Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranololG G Geyskes, P Boer, J Vos, et al.
Ciba Foundation Symposium|January 1, 1977
Superactivity of phosphoribosylpyrophosphate synthetase, due to feedback resistance, causing purine overproduction and goutO Sperling, P Boer, S Brosh, et al.
Kidney International|January 1, 1982
Plasma aldosterone concentrations in chronic renal diseaseR J Hené, P Boer, H A Koomans, et al.
The Journal of Clinical Investigation|August 1, 1976
De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiencyS Brosh, P Boer, B Kupfer, et al.
Journal of Human Hypertension|September 14, 2004
Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatmentJ M Willemsen, T J Rabelink, P Boer, et al.
Mathematical Biosciences|May 8, 2010
Ecological consequences of global bifurcations in some food chain modelsGeorge A K van Voorn, Bob W Kooi, Martin P Boer
International Journal of Clinical Pharmacology and Biopharmacy|January 1, 1978
Pharmacologic studies in Bartter's syndrome: effect of DDAVP and indomethacin on renal concentrating operation. Part IIJ P Radó, T Simatupang, P Boer, et al.
Cognitive Behaviour Therapy|January 12, 2023
Is schema therapy effective for adults with eating disorders? A systematic review into the evidencePhoebe R Joshua, Vivienne Lewis, Sally F Kelty, et al.
Journal of Medicine|January 1, 1979
"Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone productionJ P Rado, P Boer, E J Dorhout Mees, et al.
Pageof 22

Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Clinical Science and Molecular Medicine. Supplement|December 1, 1976
Change in the renin dependency of blood pressure induced by volume depletion and/or propranolol therapy in hypertensive patientsG G Geyskes, P Boer, J Vos, et al.
Lancet (London, England)|May 15, 1976
Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranololG G Geyskes, P Boer, J Vos, et al.
Ciba Foundation Symposium|January 1, 1977
Superactivity of phosphoribosylpyrophosphate synthetase, due to feedback resistance, causing purine overproduction and goutO Sperling, P Boer, S Brosh, et al.
Kidney International|January 1, 1982
Plasma aldosterone concentrations in chronic renal diseaseR J Hené, P Boer, H A Koomans, et al.
The Journal of Clinical Investigation|August 1, 1976
De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiencyS Brosh, P Boer, B Kupfer, et al.
Journal of Human Hypertension|September 14, 2004
Disparate systemic and renal blocking properties of angiotensin II antagonists during exogenous angiotensin II administration: implications for treatmentJ M Willemsen, T J Rabelink, P Boer, et al.
Mathematical Biosciences|May 8, 2010
Ecological consequences of global bifurcations in some food chain modelsGeorge A K van Voorn, Bob W Kooi, Martin P Boer
International Journal of Clinical Pharmacology and Biopharmacy|January 1, 1978
Pharmacologic studies in Bartter's syndrome: effect of DDAVP and indomethacin on renal concentrating operation. Part IIJ P Radó, T Simatupang, P Boer, et al.
Cognitive Behaviour Therapy|January 12, 2023
Is schema therapy effective for adults with eating disorders? A systematic review into the evidencePhoebe R Joshua, Vivienne Lewis, Sally F Kelty, et al.
Journal of Medicine|January 1, 1979
"Outpatient hyperkalemia" syndrome in renal and hypertensive patients with suppressed aldosterone productionJ P Rado, P Boer, E J Dorhout Mees, et al.
Pageof 22